Latest Coronary artery disease Stories

Cardium Therapeutics' Generx product for patients myocardial ischemia and chest pains to be delivered noninvasively with standard angioplasty catheter to patients in Russia Cardium Therapeutics (NYSE Amex: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA. The new research findings demonstrate that cardiac ischemia...

SAN DIEGO, May 16, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting being held May 16-19, 2012 at the Pennsylvania Convention Center in Philadelphia, PA. (Photo: http://photos.prnewswire.com/prnh/20120516/LA07787) (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) The new research findings demonstrate that cardiac ischemia plays...

PARIS, May 15, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the XIENCE PRIME(TM) and the XIENCE V® Everolimus Eluting Coronary Stent Systems have received CE Mark in Europe for the use of dual anti-platelet therapy (DAPT) for at least three months after stent implantation in patients with coronary artery disease. This is the shortest duration of DAPT for any major drug eluting stent (DES) in Europe. Patients are prescribed DAPT, a combination of aspirin and...

A new way to predict the risk of sudden cardiac arrest has been identified by translational medicine researchers at UB New research from the University at Buffalo suggests that cardiologists may have a new way to identify patients who are at the highest risk of sudden cardiac arrest, and the most likely to benefit from receiving an implantable cardiac defibrillator (ICD). ICDs are used to prevent sudden cardiac arrest in patients with advanced heart disease, but many patients' devices...

Changes in technology, clinical practice prompt updated recommendations Modern cardiac catheterization laboratories bear scant resemblance to the cath labs of a decade ago. An updated consensus statement released today offers physicians guidance on how to excel in this new diagnostic and therapeutic milieu, with specific recommendations on setting up, operating and maintaining the highest standards of quality in a contemporary cardiac catheterization laboratory. The consensus statement...

(Ivanhoe Newswire) – Stress can have many negative impacts in one’s life. While some can get it under control, others may have a hard time doing it and have to pay the price, especially if you are female! New research shows women are more likely than men to have symptoms of heart trouble after emotional upsets. The researchers recruited 17 healthy adults, a near equal mix of men and women. Each volunteer had his or her heart rate and blood pressure measured at rest, as well as coronary...

Variation rates not fully explained by community rates for risk factors, heart attack, or cardiac mortality Regional differences in rates of cardiac procedures have increased in Michigan over the past decade—not fully explained by differences in health risk factors, heart attack or cardiac mortality rates—according to a report released today by the Center for Healthcare Research & Transformation (CHRT). The report compares the state's hospital referral regions (HRRs) using claims...

Variation rates not fully explained by community rates for risk factors, heart attack, or cardiac mortality ANN ARBOR, Mich., April 30, 2012 /PRNewswire-USNewswire/ -- Regional differences in rates of cardiac procedures have increased in Michigan over the past decade--not fully explained by differences in health risk factors, heart attack or cardiac mortality rates--according to a report released today by the Center for Healthcare Research & Transformation (CHRT). The report...

UT Southwestern Medical Center researchers have demonstrated for the first time that the heart can regulate energy balance throughout the body, a finding that may point to more effective treatments for obesity, diabetes, and heart disease. Obesity, cardiovascular disease, and diabetes affect tens of millions of people in the U.S., according to the Centers for Disease Control and Prevention. Using mice fed a high-fat diet, researchers found that manipulating a heart-specific genetic...

SOUTH SAN FRANCISCO, Calif., April 26, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the inclusion of its vascular-specific inflammatory marker Lp-PLA2 in the American Association of Clinical Endocrinologists ("AACE") medical guidelines for clinical practice published in the March/April 2012 issue of Endocrine Practice. "The AACE's guidelines...